Cargando…
Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance
Over 21,000 women are diagnosed with ovarian cancer (OC) in the United States each year and over half that number succumb to this disease annually, often due to recurrent disease. A deeper understanding of the molecular events associated with recurrent disease is needed to identify potential targets...
Autores principales: | Visco, Zachary R., Sfakianos, Gregory, Grenier, Carole, Boudreau, Marie-Helene, Simpson, Sabrina, Rodriguez, Isabel, Whitaker, Regina, Yao, Derek Y., Berchuck, Andrew, Murphy, Susan K., Huang, Zhiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019902/ https://www.ncbi.nlm.nih.gov/pubmed/33828978 http://dx.doi.org/10.3389/fonc.2021.620873 |
Ejemplares similares
-
Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
por: Huang, Zhiqing, et al.
Publicado: (2023) -
Claudin Proteins in Ovarian Cancer
por: Morin, Patrice J.
Publicado: (2007) -
Expression signatures of TP53 mutations in serous ovarian cancers
por: Bernardini, Marcus Q, et al.
Publicado: (2010) -
EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications
por: Voutsadakis, Ioannis A.
Publicado: (2023) -
Claudin-4 localization in epithelial ovarian cancer
por: Neville, Margaret C., et al.
Publicado: (2022)